Back to top
more

Cardlytics (CDLX)

(Delayed Data from NSDQ)

$11.59 USD

11.59
645,815

+0.07 (0.56%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $11.57 -0.02 (-0.13%) 5:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (150 out of 251)

Industry: Technology Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Analysts Estimate Cardlytics, Inc. (CDLX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fiserv (FISV) to Post Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Fiserv's (FISV) second-quarter 2019 results to reflect revenue growth and better operating performance.

IQVIA (IQV) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

IQVIA's (IQV) second-quarter 2019 results are likely to benefit from continued market penetration of analytics and technology-enabled offerings across the company's TAS and R&DS businesses.

Here's Why Momentum Investors Will Love Cardlytics, Inc. (CDLX)

by Zacks Equity Research

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

All You Need to Know About Cardlytics, Inc. (CDLX) Rating Upgrade to Strong Buy

by Zacks Equity Research

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Moving Average Crossover Alert: Cardlytics

by Zacks Equity Research

Cardlytics, Inc. (CDLX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Cardlytics (CDLX) Catches Eye: Stock Jumps 7.4%

by Zacks Equity Research

Cardlytics (CDLX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Zacks.com featured highlights include: ADTRAN, Cardlytics, Molina and Carlisle

by Zacks Equity Research

Zacks.com featured highlights include: ADTRAN, Cardlytics, Molina and Carlisle

Bet on These 4 Top Liquid Stocks for Solid Returns

by Zacks Equity Research

Here are four impressive liquid stocks that are poised to offer marvelous returns.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for May 30th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday:

Cardlytics, Inc. (CDLX) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Cardlytics, Inc. (CDLX).

Cardlytics, Inc. (CDLX) Upgraded to Buy: Here's Why

by Zacks Equity Research

Cardlytics, Inc. (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cardlytics, Inc. (CDLX) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 37.84% and -0.03%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Cardlytics, Inc. (CDLX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Verisk (VRSK) to Post Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Organic growth, lower tax rate and contributions from acquisitions are likely to boost Verisk's (VRSK) Q4 results.

Dun & Bradstreet (DNB) Misses Q2 Earnings, Unveils Sale Plan

by Zacks Equity Research

Dun & Bradstreet's (DNB) second-quarter 2018 results were negatively impacted by timing shifts of several large contracts.

    Delphi Technologies (DLPH) Beats on Q2 Earnings, Tweaks View

    by Zacks Equity Research

    Delphi Technologies (DLPH) second-quarter 2018 earnings decline year over year but sales improve.

      Genpact (G) Q2 Earnings Beat Estimates, '18 Revenue View Up

      by Zacks Equity Research

      Genpact (G) second-quarter 2018 earnings fall year over year due to higher tax rate.

        Navigant (NCI) Q2 Earnings and Revenues Surpass Estimates

        by Zacks Equity Research

        Navigant (NCI) rides on continued strong demand across most of its businesses and disciplined cost management.

          CRA International (CRAI) Q2 Earnings Beat, Revenue View Up

          by Zacks Equity Research

          CRA International (CRAI) second-quarter 2018 results benefit from strength across services and geographies.

            Avis Budget (CAR) Earnings to Reflect Volume Growth in Q2

            by Zacks Equity Research

            The spring and summer vacations represent the peak season for Avis Budget (CAR).

              4 Business Services Stocks Poised to Beat Earnings Estimates

              by Zacks Equity Research

              The business services sector continues to benefit from a strong U.S. economy, reduced tax rates, robust manufacturing and non-manufacturing activities.